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Endemic Pemphigus Foliaceus:
Towards Understanding Autoimmune
Mechanisms of Disease Development
Giovanni Di Zenzo1, Giovanna Zambruno1 and Luca Borradori2
Fogo selvagem is an endemic form of pemphigus foliaceus (EPF) found in Brazil.
Environmental and genetic factors are thought to contribute to the disease, which
is associated with pathogenic IgG4 autoantibodies against the desmosomal
cadherin desmoglein 1. In this issue, as an additional framework to understand
autoimmune mechanisms in EPF, Flores et al. have investigated whether fogo
selvagem patients and healthy individuals from endemic areas develop autoanti-
body responses against other desmosomal cadherins and E-cadherin.
Journal of Investigative Dermatology (2012) 132, 2499–2502; doi:10.1038/jid.2012.369
Pemphigus comprises a group of poten-
tial life-threatening autoimmune blister-
ing diseases of the skin and mucous
membranes. This group of diseases is
characterized by autoimmune responses
directed specifically against two trans-
membrane components of desmosomes,
desmoglein (Dsg) 3 and Dsg1, adhesion
molecules of the cadherin family. Addi-
tional targeted antigens have been
identified recently, the pathogenic signi-
ficance of which has not been demon-
strated conclusively. The two major
forms of the disease—pemphigus vul-
garis (PV) and pemphigus foliaceus
(PF)—differ clinically. PF develops as
either sporadic disease occurring all over
the world or in an endemic form. The
latter is found mainly in certain areas of
Brazil, where the disease is known as
fogo selvagem (wildfire), as well as in
other South and Central American coun-
tries (Diaz et al., 1989; Abre`u-Velez
et al., 2003). Finally, an endemic form
of PF has been also described in North
Africa (Kallel Sellami et al., 2004).
Although endemic PF (EPF) and the
sporadic form share similar clinicopatho-
logical features and the presence of patho-
genic IgG anti-Dsg1 antibodies, fogo
selvagem has peculiar characteristics.
Fogo selvagem and its unique
epidemiology
Over the past 25 years, Diaz and the
Cooperative Group on Fogo Selvagem
Research have carried out a series of
remarkable epidemiologic and immuno-
logic studies on a specific population of
Amerindians living in the Terena reser-
vation of Limao Verde in Mato Grosso
do Sul, Brazil. In this population, the
prevalence of EPF is approximately
3.5%. Most of the affected patients are
children and young adults, who often
work outdoors and live in forested areas
near rivers and streams, in poor hygienic
and housing conditions. A strong rela-
tionship has been found between the
occurrence of fogo selvagem and
infestation with hematophagous insects
such as Simulium (also called black
fly; Aoki et al., 2004). Strikingly, up to
80% of subjects living in these areas
who suffer from hematophagous vector-
borne parasitic diseases such as
onchocerciasis, leishmaniasis, and
Chagas disease also exhibit anti-Dsg1
antibodies (Diaz et al., 2004). Patients
with fogo selvagem show circulating
IgM and IgE anti-Dsg1 antibodies,
which have been thought to result
from continuous antigenic stimulation
(Qian et al., 2011). Together, these obser-
vations have supported the idea that
environmental factors have a key role in
triggering EPF in individuals with certain
HLA susceptibility genes, especially
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DRB1*0404 and DRB1*1402 or DRB1*
1406 (Moraes et al., 1997).
Fogo selvagem and dissection of the
autoimmune mechanisms leading to
overt disease in endemic areas
Warren et al. have previously shown
that a high percentage of healthy indi-
viduals (up to 55%) living in fogo
selvagem endemic areas have low levels
of anti-Dsg1 antibodies, and that onset
of EPF is associated with anti-Dsg1 anti-
body subclass switching from IgG1 to
IgG4. The latter represents the predomi-
nant and pathogenic autoantibodies found
in sporadic PF (Warren et al., 2003).
Furthermore, overt disease is accom-
panied by the emergence of patho-
genic antibodies directed specifically
against the N-terminal region of Dsg1
ectodomain (EC1 and EC2 subdomains;
Li et al., 2003), whereas patients in the
preclinical stage and healthy indivi-
duals from endemic areas possess
IgG1-circulating autoantibodies that
recognize nonpathogenic epitopes in the
C-terminal portion of the Dsg1 ecto-
domain (EC5 subdomain). On the basis
of these findings, a model has been pro-
posed in which an environmental antigen
showing molecular mimicry with Dsg1
triggers a nonpathogenic IgG1 antibody
response to the EC5 subdomain of Dsg1.
Overt disease occurs subsequently only in
genetically susceptible individuals, and it
is associated with both a subclass switch
leading to the production of pathogenic
IgG4 anti-Dsg1 antibodies and epitope
spreading, with the development of reac-
tivity against the EC1 and EC2 domains
of Dsg1 (Figure 1). Although the epi-
demiologic and immunologic character-
istics of affected patients are not identical
to those of patients with fogo selvagem,
this model likely applies also to the EPF
found in Tunisia (Kallel Sellami et al.,
2004).
Dsg1 and beyond in fogo selvagem:
a role for other keratinocyte cadherins?
As an additional important element in
the framework to understand autoim-
mune mechanisms in EPF, Flores et al.
(2012) and the Cooperative Group on
Fogo Selvagem Research have investi-
gated whether fogo selvagem patients
develop autoantibody responses against
other desmosomal cadherins and
E-cadherin.
The desmosomal cadherin family
comprises four Dsgs (Dsg1–4) and three
desmocollins (Dsc1–3), which share
a common molecular organization with
five extracellular subdomains, a trans-
membrane subdomain, an intracellular
anchor subdomain, and a cytoplasmic
subdomain. A similar structural organi-
zation with five extracellular sub-
domains is also found in classic cadher-
ins, such as E-cadherin. Although Dsg3
and 1 are the major targets of patho-
genic autoantibodies in mucosal domi-
nant PV and PF, respectively, several
studies have described autoantibody
responses to other members of the
cadherin family in patients with different
forms of pemphigus. Specifically, Dscs
are antigenic targets in IgA pem-
phigus and in a subset of PV patients,
although antibodies binding to Dsg4
and E-cadherin have also been detected
in mucocutaneous PV and PF sera
(Nagasaka et al., 2004; Evangelista
et al., 2008; Rafei et al., 2011; Tsuruta
et al., 2011). However, antibodies to
Dsg4 in PV and PF exclusively repre-
sent cross-reactivity with a subset of anti-
Dsg1 autoantibodies, and the same holds
true for most PV and PF sera with auto-
antibodies against E-cadherin (Nagasaka
et al., 2004; Evangelista et al., 2008).
Endemic pemphigus
vulgaris prototypes the
interplay of environment
with susceptibility genes.
Flores et al., 2012 have thus assessed
IgG reactivities against Dsg1–4 and
Dsc1–3, as well as E-cadherin, in a large
cohort of fogo selvagem patients
(n¼ 111), in healthy controls living in
the Limao Verde endemic region (ende-
mic controls, n¼106), and in normal
individuals from a nonendemic area
(US controls, n¼ 106). By using ELISA
assays, they detected antibody
responses against several keratinocyte
cadherins in addition to Dsg1 in EPF
and in endemic control sera. Specifi-
cally, they found significantly higher
index values (i) for Dsg4, Dsc3, and
E-cadherin in endemic controls than in
US controls; (ii) for Dsg1–3 and Dsc1 in
EPF patients than in endemic controls;
and (iii) for Dsg1-3, Dsc1 and 3, and
E-cadherin, in EPF patients than in US
controls. Anti-E-cadherin IgG antibodies
were detectable in a significant percen-
tage of sera from endemic control (58%)
and EPF (42%) groups. In endemic
controls, Flores et al.( 2012) observed
a striking correlation between the pre-
sence of anti-Dsg1 autoantibodies and
reactivity with Dsg3, Dsg4, Dsc1-3, and
E-cadherin. Furthermore, US controls
showed unexplained higher reactivities
against Dsg3 and Dsc2 than in the
endemic controls and EPF patients,
respectively. Finally, the investigators
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Figure 1. Current etiopathogenetic model for endemic pemphigus foliaceus.
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assessed the diagnostic performance of
their ELISAs. They found that the
frequency of positive EPF and endemic
control sera for all the tested antigens,
except Dsc3 and Dsg3, was above
20%. However, given the relatively
low sensitivity, none of the cadherin-
based ELISAs, with the exception of the
Dsg1 assay, appeared useful as a
diagnostic test for EPF.
Nevertheless, some caution should
be exercised with the findings of Flores
et al. (2012). First, the reliability of the
ELISA data comparisons is to some
extent weakened by the high levels
for negative controls and by saturated
ELISA values. Second, immunoblotting
and immunofluorescence studies would
have been useful to support the findings
obtained by ELISA, at least for selec-
ted cadherin molecules not previously
tested. Finally, the authors did not
conduct studies to determine whether
the detected anti-Dsc1-3, anti-Dsg1-4,
and anti-E cadherin antibodies were
independent antibody responses or
represented cross-reactivities. However,
the same group has provided evidence
previously that most of the anti-
E-cadherin antibodies cross-react with
Dsg1 in pemphigus patients because of
the high homology between these two
molecules, although others represent
independent antibodies (Evangelista
et al., 2008). Furthermore, the reacti-
vity detected previously for Dsg4 in
pemphigus patients has been attributed
to cross-reactivities for a subset of
anti-Dsg1 antibodies (Nagasaka et al.,
2004).
On the basis of their findings, Flores
et al. (2012) put forward novel specu-
lation about the pathogenesis of EPF.
The earliest response in healthy indivi-
duals from endemic areas, which may
be environmentally triggered, might be
directed against one of the keratinocyte
cadherins that is recognized differently
in the endemic and normal controls,
such as E-cadherin. This initial res-
ponse is followed by the production of
autoantibodies against other keratino-
cyte cadherins, most likely Dsg1-3,
Dsc1, and Dsc3. This immune res-
ponse may either reflect cross-reactivity
and/or be due to intermolecular epitope
spreading, subsequently leading to the
generation of highly specific and
pathogenic IgG4 autoantibodies that
are responsible for overt disease.
Qian et al. (2012) have recently
reported that salivary gland antigens
from the sand fly, which is a vector for
leishmaniasis, are recognized by IgG4
and IgE antibodies from EPF patients.
Intriguingly, these investigators demon-
strated further that mice immunized
with one of these fly antigens produce
anti-Dsg1 antibodies (Qian et al., 2012).
Although there is no sequence similarity
between Dsg1 and the fly antigens,
cross-reactivity may occur in response
to the presence of the same confor-
mational epitopes on both molecules.
Surprisingly, the antibody titers against
the salivary gland antigens in endemic
controls were similar to those detected
in the US controls. It is conceivable that
the fly salivary gland epitope mimics a
pathogenic epitope in the EC1/EC2
subdomains of Dsg1, resulting in the
induction, in the endemic patients, of a
cross-reactive anti-Dsg1 immune res-
ponse that, in genetically predisposed
individuals, leads directly to overt
disease. Hence, it would be of interest
to assess whether the recognized sali-
vary gland epitopes (and other potential
triggering antigens) are shared by kerati-
nocyte cadherins and, in particular, by
E-cadherin. The latter was suggested
by Flores et al. (2012) to act as pos-
sible link between the immune response
of endemic controls and that of EPF
patients.
Interplay of genetic and environmental
factors in the development of endemic PF
The strong associations with distinct
HLA class II alleles reported in both
Brazilian and Tunisian EPF patients
(Abida et al., 2009) implies that genetic
factors influence the development of
EPF. In this context, the report by
Flores et al. (2012) does not provide
new data concerning the relative contri-
butions of environmental and genetic
factors to the autoantibody responses in
EPF patients or in healthy individuals
living in endemic areas. The predispo-
sing role of HLA and other susceptibility
genes in the complex pathogenesis of
EPF requires further characterization.
Recently, we isolated several anti-
Dsg3 pathogenic IgG monoclonal
antibodies from PV patients. These
autoantibodies carried high levels of
somatic mutations in complementary
determining regions, consistent with
antigen selection. Remarkably, binding
of antibodies to Dsg3 was lost when
somatic mutations were reverted to the
germline sequence, suggesting the role
of a different antigen as the primary
trigger in the development of the
immune response leading to PV (Di
Zenzo et al., 2012). Our findings are,
thus, in line with available data in EPF,
indicating that autoreactivity to Dsg1
could be generated following the
recognition of a disease-triggering anti-
gen most likely unrelated to Dsg1. In
addition, a recent study by Qian et al.
(2009) showed that hybridomas esta-
blished from B cells from an EPF
patient before and after disease onset
share multiple replacement mutations.
This observation strongly suggests that
antigen selection occurs well before the
onset of disease. Hence, characteri-
zation of the antigenic targets of germ-
line antibodies, obtained through the
reversion of somatic mutations of anti-
Dsg1 monoclonal antibodies isolated
from EPF patients, may provide novel
insights into the pathogenesis of EPF and
other human autoimmune diseases.
It is hoped that the Cooperative
Group on Fogo Selvagem Research, as
well as other laboratories, will continue
their efforts with epidemiologic, genetic,
and immunologic studies aimed at
further dissecting the mechanisms
leading to EPF. EPF has emerged as a
prototypic model for the study of the
relationship and interplay between
environmental triggering factors and
susceptibility genes, which will prove
useful and important for understanding
a variety of other organ-specific auto-
immune diseases.
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Activation of the Unfolded Protein
Response in Vitiligo: The Missing Link?
Thierry Passeron1,2 and Jean-Paul Ortonne1
Vitiligo is characterized by a substantial loss of functional melanocytes in the
epidermis and sometimes in hair follicles. Genetic and pathophysiological studies
have provided strong evidence that vitiligo is a polygenetic, multifactorial disorder.
The key roles of oxidative stress within melanocytes and anti-melanocyte immune
responses have been addressed in many studies, but the relationship between
these mechanisms remains unclear. In this issue, Toosi et al. report the
upregulation of IL-6 and IL-8 after the activation of the unfolded protein response
(UPR) following exposure of melanocytes to phenols. Their results shed light on
the missing link between oxidative stress and immune responses in vitiligo.
Journal of Investigative Dermatology (2012) 132, 2502–2504; doi:10.1038/jid.2012.328
Oxidative stress in vitiligo
Vitiligo melanocytes long have been
known to have a low replication rate in
culture, requiring catalase supplementa-
tion for their growth and showing struc-
tural aberrations, such as dilated endo-
plasmic reticulum (Boissy et al., 1991).
High levels of hydrogen peroxide have
been found in the vitiligo epidermis
(Schallreuter et al., 1999). Indeed,
vitiligo melanocytes are the theater of
a redox balance loss because of high
levels of toxic catechol metabolites,
high free-radical levels, and defective
antioxidant machinery (Dell’anna and
Picardo, 2006). In culture, vitiligo mela-
nocytes are highly susceptible to
chemical and physical oxidative stress.
The overactivation of some sources of
reactive oxygen species (ROS), the role
of NADPH oxidase in ROS formation
caused by extracellular and intracellular
factors/conditions, and deficiencies in
one or more of the reducing agents and
detoxifying enzymes are responsible for
this redox homeostasis impairment. Dys-
function of catalase, superoxide dismu-
tase, glutathione peroxidase, thioredoxin
peroxidase, thioredoxin reductase, and
g-glutamyl transpeptidase has been repor-
ted extensively for vitiligo. The first
evidence supporting the concept that
stressed melanocytes could activate an
immune response was provided by the
identification of activated dendritic cells
after intrinsic damage to melanocytes due
to 4-tertiary butyl phenol exposure (Kroll
et al., 2005).
Vitiligo, an autoimune disorder
Studies of the infiltrate in perilesional
epidermis of vitiligo skin reveal predo-
minantly CD8þ cells (Lili et al., 2012).
A recent mouse model of vitiligo, with
a phenotype similar to that observed in
humans, was developed using melano-
cyte-specific CD8þ T cells (Harris et al.,
2012). Interestingly, in this model, the
inhibition of IFN-g with antibody pre-
vents the development of depigmen-
tation. Th1 and, more recently, the Th17
cytokine environment have been impli-
cated in the pathophysiology of vitiligo
(Wang et al., 2011; Kotobuki et al., 2012).
Dermal dendritic cells with activated
inflammasomes have been found at the
edges of vitiligo lesions, and they could
participate in the Th17 activation (Wang
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